Dortet L, et al. - This study was designed to assess the performance of the Carbapenemase Detection Set (CDS; Mast Diagnostics) in association with the EUCAST meropenem screening cut-off vs the faropenem–temocillin algorithm (FTa) for the screening of carbapenemase-producing Enterobacteriaceae (CPE). Researchers noted that the association of the CDS with the FTa presented only 22% of inconclusive results, while this number was 38% with the EUCAST meropenem CPE screening cut-off.